Biocompatible Rhamnolipid Self-Assemblies with Ph-Responsive Antimicrobial Activity.
Parth KadakiaJules ValentinLinda HongSamuel WattsOwais Abdul HameedMichael WalchStefan SalentinigPublished in: Advanced healthcare materials (2023)
There is an urgent need for alternative antimicrobial materials due to the growing challenge of bacteria becoming resistant to conventional antibiotics. This study demonstrates the creation of a biocompatible pH-switchable antimicrobial material by combining bacteria-derived rhamnolipids (RL) and food-grade glycerol monooleate (GMO). The integration of RL into dispersed GMO particles, with an inverse-type liquid crystalline cubic structure in the core, leads to colloidally stable supramolecular materials. The composition and pH-triggered structural transformations are studied with small-angle X-ray scattering, cryogenic transmission electron microscopy, and dynamic light scattering. The composition-structure-activity relationship is analyzed and optimized to target bacteria at acidic of acute wounds. The new RL/GMO dispersions reduce Staphylococcus aureus populations by 7-log after 24 h of treatment with 64 μg mL -1 of RL and prevent biofilm formation at pH = 5.0, but have no activity at pH = 7.0. Additionally, the system is active against methicillin-resistant S. aureus (MRSA) with MIC = 128 μg mL -1 at pH 5.0. No activity was found against several Gram-negative bacteria at pH 5.0 and 7.0. The results provide a fundamental understanding of lipid self-assembly and the design of lipid-based biomaterials, which can further guide the development of alternative bio-based solutions to combat bacteria . This article is protected by copyright. All rights reserved.
Keyphrases
- staphylococcus aureus
- biofilm formation
- electron microscopy
- methicillin resistant staphylococcus aureus
- ionic liquid
- pseudomonas aeruginosa
- high resolution
- magnetic resonance imaging
- intensive care unit
- candida albicans
- computed tomography
- structure activity relationship
- risk assessment
- magnetic resonance
- cystic fibrosis